This information was published on 2025-08-28T02:27:09 for IP Right Filed Published.
| Field | Value |
| (210) | 2581518 (IR 1872108) |
| (220) |
22 Jul 2025
|
| (300) |
US, 06 Feb 2025, 99031170
|
| (511) (510) |
Class 5
Pharmaceuticals and medicines for the treatment of cystic fibrosis, pain, sickle cell disease, beta thalassemia, muscular dystrophy, diabetes, respiratory diseases, liver disease, kidney disease, alpha-1 antitrypsin deficiency and APOL1-mediated kidney disease. |
| (540) | VOXJEMI |
| (550) | Word |
| (730) |
Vertex Pharmaceuticals Incorporated
|
Find out more about publications on the About page.